Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology-Reference-Cited by-同舟云学术

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology

Published:2019-06 Issue: Volume:81 Page:88-94
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Zinzani Pier Luigi,Rambaldi Alessandro,Gaidano Gianluca,Girmenia Corrado,Marchetti Monia,Pane Fabrizio,Tura Sante,Barosi Giovanni^ORCID

Funder

Italian Society of Hematology

SIE society

at-arm’s-length contribution from Gilead

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference56 articles.

1. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls;Moreira;Leukemia,2013

2. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study;Andersen;Haematologica,2018

3. X-linked agammaglobulinemia: report on a United States registry of 201 patients;Winkelstein;Medicine (Baltimore),2006

4. Identification of a role for the PI3K/AKT/mTOR signaling pathway in innate immune cells;Xie;PLoS One,2014

5. Ibrutinib

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10

2. Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections;Expert Review of Hematology;2023-04-03

3. Clinical Experience with Phosphatidylinositol 3‐Kinase Inhibitors in Hematologic Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

4. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA);Frontiers in Oncology;2022-10-04

5. La leucémie lymphoïde chronique;La Revue de Médecine Interne;2022-06